The Carlyle Group, an alternative asset manager, has appointed Jesse Wu as the new senior advisor for its Asia buyout team.
Go deeper with GlobalData
Access deeper industry intelligence
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
Wu previously served a 26-year spell at Johnson & Johnson, a group which he joined in 1989. He held the role of the chairman of Johnson & Johnson China and the member of the company’s management committee from 2013 to 2016.
He also served as the worldwide chairman of the Johnson & Johnson Consumer Group and company group chairman for global markets.
Overall, Wu has an experience of about three decades in the healthcare and related sectors.
Carlyle Asia buyout team managing director and co-head X.D. Yang said: "We are thrilled to welcome Jesse Wu, a global business leader and experienced healthcare expert, as an advisor to Carlyle.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData"With his deep healthcare industry expertise and highly respected senior management capabilities, Jesse will be a great resource for our team and our portfolio companies as we continue to expand our investments in the fast-growing healthcare sector and other related industries in China and across Asia.
"Our buyout team in Asia has been a leader in investing in healthcare with more than $1.3 billion of equity invested in seven companies across the Asia-Pacific region and we remain greatly excited about future investment opportunities."
The Carlyle Asia buyout team has invested over $1.3bn of equity in seven companies till date.
